Peripheral cardiovascular effects, in the pithed rat, of compounds used in the treatment of hypertension.
D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects*; D003000:Clonidine / Q000494:pharmacology; D002818:Cordotomy; D003981:Diazoxide / Q000494:pharmacology; D004558:Electric Stimulation; D004878:Ergotamine / Q000494:pharmacology; D006145:Guanethidine / Q000494:pharmacology; D006852:Hydrochlorothiazide / Q000494:pharmacology; D007490:Iproniazid / Q000494:pharmacology; D008297:Male; D008464:Mecamylamine / Q000494:pharmacology; D008750:Methyldopa / Q000494:pharmacology; D010293:Pargyline / Q000494:pharmacology; D010634:Phenobarbital / Q000494:pharmacology; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D013564:Sympathetic Nervous System / Q000187:drug effects; D013861:Thiocyanates / Q000494:pharmacology; D014294:Trimethaphan / Q000494:pharmacology
D000959:Antihypertensive Agents; D013861:Thiocyanates; D006852:Hydrochlorothiazide; D008750:Methyldopa; D008464:Mecamylamine; D014294:Trimethaphan; D012110:Reserpine; D010293:Pargyline; D007490:Iproniazid; D003000:Clonidine; D003981:Diazoxide; D004878:Ergotamine; D010634:Phenobarbital; D006145:Guanethidine